Clinical trial
Evaluation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule for Small Intestinal Dysbiosis
NCT05633706 is registered in ClinicalTrials.gov with Nimble Science Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule for Small Intestinal Dysbiosis
- Lead sponsor
- Nimble Science Ltd.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 9, 2023
- Completion date
- August 31, 2027
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
celiac disease, crohn disease, functional dyspepsia, healthy, irritable bowel syndrome, type 2 diabetes, ulcerative colitis